Intensity Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.35

+0.01 (+3.01%)

As of Feb 8, 2:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +10,501.7% upside

Low Target $31.85

Average Target $37.00

High Target $43.82

Current Price $0.35

Current
$0.35

Target
$37.00

$31.85 $37.00 avg $43.82

Scenario Analysis

Bear Case

$31.85

9,026.1%

Low target

Base Case

$37.00

+10,501.7%

Avg target

Bull Case

$43.82

+12,455.9%

High target

Risk/Reward

1.4x

Balanced

Price in Context

52-Week High

$47.47

-99.3% from high

52-Week Low

$20.23

+-98.3% from low

Target vs 52W High

$37.00

-22.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%